Lehi teen undergoes the only FDA approved therapy for rare eye condition

Jessa is determined to have a normal high school experience despite living with keratoconus. An unexpected diagnosis of this rare eye condition when she was in the eighth grade led her and her family to search for an appropriate treatment option that would allow Jessa to remain an active and carefree 16-year-old. Ultimately, they decided on the only FDA approved therapeutic cross-linking treatment to slow the progression of her keratoconus.

An article in the Daily Herald spotlights Jessa’s journey with keratoconus, and how after undergoing the cross-linking procedure, she is now able to be a normal high school student. She plays on the soccer team and participates in the marching band. To learn more about Jessa and her experiences with keratoconus, read the full article.

For more information on keratoconus or to read more stories like Jessa’s, follow Living with KC on Twitter, Instagram, and Facebook.

MA-01287A

Text Optimizer